Montoya A - Search Results

1

Clinical characteristics of agitated psychotic patients treated with an oral antipsychotics attended in the emergency room setting: NATURA study.

Montoya A, San L, Manuel Olivares J, Pérez-Sola V, Casillas M, López-Carrero C, Polavieja P, Escobar R. Montoya A, et al. Int J Psychiatry Clin Pract. 2008;12(2):127-33. doi: 10.1080/13651500701749859. Int J Psychiatry Clin Pract. 2008. PMID: 24916623

2

[Effectiveness results of olanzapine in acute psychotic patients with agitation in the emergency room setting: results from NATURA study].

Escobar R, San L, Pérez V, Olivares JM, Polavieja P, López-Carrero C, Casillas M, Montoya A. Escobar R, et al. Among authors: montoya a. Actas Esp Psiquiatr. 2008 May-Jun;36(3):151-7. Actas Esp Psiquiatr. 2008. PMID: 18478455 Free article. Clinical Trial. Spanish.

3

Validation of the Excited Component of the Positive and Negative Syndrome Scale (PANSS-EC) in a naturalistic sample of 278 patients with acute psychosis and agitation in a psychiatric emergency room.

Montoya A, Valladares A, Lizán L, San L, Escobar R, Paz S. Montoya A, et al. Health Qual Life Outcomes. 2011 Mar 29;9:18. doi: 10.1186/1477-7525-9-18. Health Qual Life Outcomes. 2011. PMID: 21447155 Free PMC article.

4

Functioning and symptomatic outcomes in patients with bipolar I disorder in syndromal remission: a 1-year, prospective, observational cohort study.

Montoya A, Tohen M, Vieta E, Casillas M, Chacón F, Polavieja P, Gilaberte I. Montoya A, et al. J Affect Disord. 2010 Dec;127(1-3):50-7. doi: 10.1016/j.jad.2010.04.026. Epub 2010 Jun 16. J Affect Disord. 2010. PMID: 20557947

5

Evaluation of patients' and parents' quality of life in a randomized placebo-controlled atomoxetine study in attention-deficit/hyperactivity disorder.

Escobar R, Montoya A, Polavieja P, Cardo E, Artigas J, Hervas A, Fuentes J. Escobar R, et al. Among authors: montoya a. J Child Adolesc Psychopharmacol. 2009 Jun;19(3):253-63. doi: 10.1089/cap.2008.0109. J Child Adolesc Psychopharmacol. 2009. PMID: 19519260 Clinical Trial.

6

Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder.

Montoya A, Hervas A, Cardo E, Artigas J, Mardomingo MJ, Alda JA, Gastaminza X, García-Polavieja MJ, Gilaberte I, Escobar R. Montoya A, et al. Curr Med Res Opin. 2009 Nov;25(11):2745-54. doi: 10.1185/03007990903316152. Curr Med Res Opin. 2009. PMID: 19785510 Clinical Trial.

7

Cluster-randomized, controlled 12-month trial to evaluate the effect of a parental psychoeducation program on medication persistence in children with attention-deficit/hyperactivity disorder.

Montoya A, Hervás A, Fuentes J, Cardo E, Polavieja P, Quintero J, Tannock R. Montoya A, et al. Neuropsychiatr Dis Treat. 2014 Jun 13;10:1081-92. doi: 10.2147/NDT.S62487. eCollection 2014. Neuropsychiatr Dis Treat. 2014. PMID: 24966679 Free PMC article.

8

Changes of urine dihydroxyphenylglycol to norepinephrine ratio in children with attention-deficit hyperactivity disorder (ADHD) treated with atomoxetine.

Montoya A, Escobar R, García-Polavieja MJ, Lachno DR, Alda JÁ, Artigas J, Cardo E, García M, Gastaminza X, Gilaberte I. Montoya A, et al. J Child Neurol. 2011 Jan;26(1):31-6. doi: 10.1177/0883073810371981. Epub 2010 Jun 4. J Child Neurol. 2011. PMID: 20525942 Clinical Trial.

9

Long-term quality-of-life and functioning comparison of atomoxetine versus other standard treatment in pediatric attention-deficit/hyperactivity disorder.

Fuentes J, Danckaerts M, Cardo E, Puvanendran K, Berquin P, De Bruyckere K, Montoya A, Quail D, Escobar R. Fuentes J, et al. Among authors: montoya a. J Clin Psychopharmacol. 2013 Dec;33(6):766-74. doi: 10.1097/JCP.0b013e31829c762b. J Clin Psychopharmacol. 2013. PMID: 23963057 Clinical Trial.

10

Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention-deficit/hyperactivity disorder, based on a pooled analysis.

Montoya A, Quail D, Anand E, Cardo E, Alda JA, Escobar R. Montoya A, et al. Atten Defic Hyperact Disord. 2014 Mar;6(1):25-34. doi: 10.1007/s12402-013-0119-5. Epub 2013 Oct 20. Atten Defic Hyperact Disord. 2014. PMID: 24142305 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

600 results

Search Page

Filters